C. Haioun

发表论文 595 篇 · 总被引 33087 次 · h-index 98

代表论文

• Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry (2023 · Blood Advances · 被引 71)
• Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study (2023 · Journal of Clinical Oncology · 被引 26)
• Glofitamab (Glofit) Plus R-CHOP Has a Favorable Safety Profile and Induces High Response Rates in Patients with Previously Untreated (1L) Large B-Cell Lymphoma (LBCL) Defined As High Risk By Circulating Tumor DNA (ctDNA) Dynamics: Preliminary Safety and Efficacy Results (2023 · Blood · 被引 18)
• Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B‐cell lymphoma. A real‐world 112‐patient cohort (2023 · British Journal of Haematology · 被引 17)
• Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low–Tumor Burden Follicular Lymphoma: Results of a LYSA Study (2023 · Journal of Clinical Oncology · 被引 14)
• Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelines. (2025 · European Journal of Cancer · 被引 13)